Stockscreener 앱 받기
1.18
1.67%
-0.02
시간 외 거래:
1.18
Biofrontera Inc 주식(BFRI)의 최신 뉴스
Biofrontera Inc.Warrants (Nasdaq:BFRIW) Detailed Stock Data - The Chronicle-Journal
Biofrontera stock gets FDA approval for skin cancer treatment By Investing.com - Investing.com Australia
Biofrontera stock gets FDA approval for skin cancer treatment - Investing.com
Biofrontera Wins FDA Approval for Ameluz in Superficial Basal Cell Carcinoma - Minichart
Form 8K Biofrontera Inc For: 14 September By Investing.com - Investing.com Nigeria
Biofrontera Gains FDA Approval for Ameluz Skin Cancer Use - TipRanks
Biofrontera wins FDA approval for Ameluz to treat skin cancer - Investing.com
Biofrontera Announces FDA Approval of Ameluz® Red Light PDT for the Treatment of Superficial Basal Cell Carcinoma - GlobeNewswire
Biofrontera Warrants (BFRIW) Hold Near $0.02 as Sub-Penny Instrument Edges LowerSynthetic Long - dars.gov.et
Biofrontera (NASDAQ:BFRI) Passes Minervini Trend Template With High-Growth Momentum - ChartMill
Biofrontera Inc. Warrants (BFRIW) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
Biofrontera Inc. Warrants (BFRIW) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
BFRI Q2 2026 Earnings: Loss Narrows Sharply, Delivering 53% EPS BeatEarnings Acceleration Picks - vinanet.vn
Biofrontera Inc. Warrants (BFRIW) Peer Comparison – Compare with Others - Value Research
Biofrontera (BFRI) Jumps 6.71% to $1.59, Testing Key Resistance Near $1.67Common Gap - vinanet.vn
Biofrontera Inc. Warrants (BFRIW) Key Financial Ratios – Valuation, Profitability & More - Value Research
Biofrontera (BFRI) Quarterly Figures: Profit Per Share Clears Its Benchmark on the Day; Share Move: Shares Show Little Net Change in Latest TradingRevenue Inflection Point - vinanet.vn
Biofrontera (BFRI) Q2 2026 Earnings Call Transcript - AOL.com
Biofrontera (BFRI) Close and Levels: Posts a 6.67% Gain to $1.44 in the Current Update; Trading Range: Price Remains Between $1.37 Support and $1.51 Resistance on the DayCall Spread Alert - vinanet.vn
Ziopharm: Q2 Earnings Snapshot - AOL.com
Biofrontera (BFRI) Climbs 3.17% to $1.30: Holding Above Key Support ZonePCR Divergence - vinanet.vn
Biofrontera Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Biofrontera Q2 2026 Earnings Call Transcript - marketbeat.com
Biofrontera Inc (BFRI) (Q2 2026) Earnings Call Highlights: Strong Ameluz Growth Drives Revenue ... - Yahoo Finance
Biofrontera Inc. (BFRI) lifts revenue yet flags going concern and ITC impact - Stock Titan
Biofrontera Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
BFRI Q2 2026 Earnings: Narrower-Than-Expected Loss Drives 6.4% Stock RallyEarnings Weakness Phase - vinanet.vn
Same Patent, Same Light- Director Vacates IPR Decision at Odds With ITC Decision - The National Law Review
Biofrontera earnings beat by $0.09, revenue topped estimates - Investing.com
Earnings call transcript: Biofrontera tops Q2 2026 estimates, shares jump 9.6% - Investing.com
BFRI: Record revenue growth, margin expansion, and strong pipeline offset ITC lamp restriction - TradingView
Biofrontera Inc. (BFRI) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance
Price to earnings forward of Biofrontera Inc. – BOATS:BFRIW - TradingView
Biofrontera Inc. (BFRI) Q2 FY2026 earnings call transcript - Yahoo Finance
Form 8K Biofrontera Inc For: 13 August By Investing.com - Investing.com Australia
BIOFRONTERA ($BFRI) Releases Q2 2026 Earnings - Quiver Quantitative
Biofrontera Reports Q2 2026 Revenue Up 33% to $12.0M, Gross Margin 80% - TradingView
Biofrontera Inc. Reports Strong Second Quarter 2026 Financial Results Driven by 33% Revenue Growth - The Manila Times
Biofrontera (BFRI) investor Rosalind discloses 9.9% stake and 9.99% blocker - Stock Titan
Earnings To Watch: Biofrontera Inc (BFRI) Q2 2026 -- GF Value Sees 51% Downside - Yahoo Finance
Earnings To Watch: Biofrontera Inc (BFRI) Q2 2026 -- GF Value Se - GuruFocus
Biofrontera Inc. Warrants (BFRIW) Hold Steady at $0.03 as Support and Resistance ConvergeMAMA Signal - dars.gov.et
Biofrontera Inc. (BFRI) Stock Major Holders - Yahoo! Finance Canada
Price to sales forward of Biofrontera Inc. – BOATS:BFRIW - TradingView
Biofrontera Inc (BFRI) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Biofrontera Inc. (BFRI) stock price, news, quote and history - Yahoo Finance Singapore
BFRI Q1 2026 Earnings: EPS Misses Estimates by 215%, Shares Edge Down 0.8%CEO Earnings Statement - careplusvn.com
BFRI Q2'26 Earnings: EPS estimate is (0.10) USD - TradingView
Biofrontera Inc. to Report Second Quarter 2026 Financial Results on August 13, 2026 - The Manila Times
Biofrontera schedules Aug. 13 webcast for business update - Stock Titan
Biofrontera (BFRI) Q1 2026 Earnings: Deep EPS Miss Reflects Rising Costs and Pipeline PressureEarnings Preview - careplusvn.com
BFRI Q2'26 Earnings: revenue estimate is 9.50M USD - TradingView
Squires Erases PTAB Ax Of Dermatology IP Upheld At ITC - Law360
Form 4 Biofrontera Inc For: 29 July By Investing.com - Investing.com Canada
Biofrontera Inc. (BFRI) Q1 2026 Earnings: EPS Misses Estimates Sharply Despite Share GainEPS Guidance Update - dars.gov.et
Biofrontera Inc. Revenue Breakdown – NASDAQ:BFRI - TradingView
PTA-Adhoc: Biofrontera AG: Biofrontera AG Resolves to Prepare Transfer from the Regulated Market (Prime Standard) to the Scale Segment - TradingView
0.18%
0.69%
자본화:
|
볼륨(24시간):